USPTO serial 99127459
DROPBOT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 2, 2026
- Examiner
- OAKES, ANNA JENNIE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DROPBOT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Toronto, ON, CA
Toronto, ON, CA
Toronto, ON, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Danielle Cohen
Danielle Cohen ELLENOFF GROSSMAN & SCHOLE LLP1345 Avenue of the AmericasFloor 11New York, NY 10105Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Laboratory, scientific, optical, and electrical research apparatus and instruments, namely, digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for automating sample preparation, droplet manipulation, and data analysis in laboratory workflows, microchannel wafers, and sensor chips for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for automating sample preparation, droplet manipulation, and data analysis in laboratory workflows, microchannel wafers, and sensor chips for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for use in automating sample preparation, droplet manipulation, and data analysis in laboratory workflows, microchannel wafers, and sensor chips for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for biological, genetic, chemical, medical, and scientific research and analysis, power controllers, and sensor chips for laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for sample preparation, manipulation, and analysis in chemical and biochemical workflows for laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for testing and measuring an attribute in assays for use in the fields of laboratory, scientific, optical and electrical research; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for single-cell and bulk-sample analyses for identifying, isolating, capturing, sorting, imaging, counting, and analyzing cells and tissue for use in the fields of laboratory, scientific, optical and electrical research; Scientific apparatus and instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biomarkers, proteins, nucleic acids, metabolites, chemical contaminants and biological contaminants; Scientific apparatus and instruments for creating, analyzing, and manipulating droplets and micro-droplets for the presence, absence, or quantity of biomarkers, proteins, nucleic acids, metabolites, chemical contaminants and biological contaminants; Kits comprising peptide substrates for preparing samples for chemical analysis, biochemical analysis, imaging microfluidic analysis, and digital microfluidic analysis; Data processing equipment for use with apparatus and instruments for creating, analysing and manipulating droplets and micro-droplets; Downloadable software for chemical and biochemical analysis in the field of scientific imaging and microfluidics; Downloadable computer software and embedded firmware for configuring, operating, and analyzing data from digital microfluidic platforms used in chemical, biochemical, and medical assays; Scientific research platform device comprised primarily of computer hardware and also including recorded software for single-cell and bulk-sample analyses for identifying, isolating, capturing, sorting, imaging, counting, and analyzing cells and tissue for use in the fields of laboratory, scientific, optical and electrical research; Scientific research platform device comprised primarily of computer hardware and recorded software for use in automating sample preparation, droplet manipulation, and data analysis in laboratory workflows; Downloadable scientific and medical data for use in chemical analysis, biochemical analysis and microfluidic analysis; Electronic circuit boards for use as controllers for digital microfluidic platform devices; Scientific laboratory research instruments for use with digital microfluidic applications in the field of medical imaging; Microscopes for use with digital microfluidic chips; Integrated digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for sample preparation for use with external analytical instruments, namely, instruments for mass spectrometry, instruments for fluorescence spectroscopy, electrochemical sensors, and nucleic acid sequencing instruments ; Remote controls for digital microfluidic platform devices and sensor chips for digital microfluidic platform devices for scientific use; Automated liquid handling systems comprised primarily of computer hardware, electronic controllers, sensor chips, and recorded computer software for automating sample preparation, droplet manipulation, and fluid dispensing in digital microfluidic workflows, and laboratory consumables, namely, pipette tips for digital microfluidic workflows; Automated liquid handling systems comprised primarily of computer hardware, electronic controllers, sensor chips, and recorded computer software for automating sample preparation, droplet manipulation, and fluid dispensing in digital microfluidic workflows; Computer hardware and downloadable computer software for controlling automated liquid handling systems; Digital microfluidic platforms comprised primarily of computer hardware and also including recorded computer software for use in agricultural testing, environmental testing and food testing for laboratory, scientific, optical and electrical research | ACTIVE | Nov 6, 2017 |
| 010 | Medical devices, namely, digital microfluidic platforms for in vitro diagnostic testing of patient samples for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Medical devices, namely, digital microfluidic platforms for sample preparation and analysis in medical and clinical research and for chemical assays, biochemical assays, and clinical diagnostics in laboratory settings for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Digital microfluidic platforms for research use in medical and life sciences applications, for cellular and molecular analysis in research and laboratory settings, and for point-of-care diagnostic testing for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; AI-assisted digital microfluidic platforms for automated biomarker detection for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Apparatus and instruments for droplet chemical and biochemical analysis for medical diagnostic purposes; Laboratory-based instruments and consumables in the nature of digital microfluidic medical analyzers and disposable medical diagnostic cartridges for medical sample preparation and analysis, namely, biomarker detection, cytokine profiling, nucleic acid analysis, and therapeutic drug monitoring for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing; Digital microfluidic chips for use in medical applications, namely, detecting biomarkers, performing immunoassays, and point-of-care diagnostic tests for the diagnosis and monitoring of hematologic disorders, coagulation disorders, infectious diseases, metabolic disorders, cardiovascular disorders, inflammatory disorders, immunologic disorders, genetic disorders, and for blood transfusion compatibility testing, namely, blood group typing | ACTIVE | Nov 6, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 2, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 2, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 14, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 14, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 8, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 2, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 2, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 2, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 29, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 29, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 29, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 19, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 8, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 8, 2025 | NWAP | NEW APPLICATION ENTERED | — |